Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

P2.01-22 ORCHARD: A Phase II Platform Study in Patients with Advanced NSCLC Who Have Progressed on First-Line Osimertinib Therapy

H. Yu, S. Goldberg,X. Le,Z. Piotrowska,P. Smith,I. Mensi, B. Kirova,J. Chmielecki, X. Li-Sucholeicki,P. Szekeres,G. Doughton,G. Patel,P. Jewsbury,J. Riess

Journal of Thoracic Oncology（2019）

Cited 21|Views55
No score
Key words
NSCLC,resistance,Osimertinib
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined